{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:31:03Z","timestamp":1790872263673,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,11]]},"DOI":"10.1097\/qad.0b013e3282f2d760","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T23:33:45Z","timestamp":1236209625000},"page":"237-247","source":"Crossref","is-referenced-by-count":73,"title":["Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells\/\u03bcl"],"prefix":"10.1097","volume":"22","member":"276","reference":[{"key":"R2-9-20210130","first-page":"CD006148","article-title":"Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.","volume":"3","author":"Pai","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R3-9-20210130","first-page":"CD005482","article-title":"Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.","volume":"4","author":"Pai","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-9-20210130","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"R5-9-20210130","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(06)68887-9","article-title":"CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial","volume":"367","author":"Danel","year":"2006","journal-title":"Lancet"},{"key":"R6-9-20210130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(06)69153-8","article-title":"CD4-guided scheduled treatment interruptions compared to continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial","volume":"368","author":"Ananworanich","year":"2006","journal-title":"Lancet"},{"key":"R9-9-20210130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","article-title":"The WHO public health approach to antiretroviral treatment against HIV in resource-limited settings","volume":"368","author":"Gilks","year":"2006","journal-title":"Lancet"},{"key":"R11-9-20210130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/QAD.0b013e3280121801","article-title":"Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy","volume":"21","author":"Kikaire","year":"2007","journal-title":"AIDS"},{"key":"R12-9-20210130","first-page":"221","article-title":"Interim proposal for a WHO staging system for HIV infection and disease.","volume":"65","year":"1990","journal-title":"Wkly Epidemiol Rec"},{"key":"R14-9-20210130","doi-asserted-by":"crossref","first-page":"F33","DOI":"10.1097\/00002030-200310170-00001","article-title":"Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial","volume":"17","author":"Ananworanich","year":"2003","journal-title":"AIDS"},{"key":"R15-9-20210130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1086\/376535","article-title":"Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters","volume":"188","author":"Dybul","year":"2003","journal-title":"J Infect Dis"},{"key":"R16-9-20210130","first-page":"457","article-title":"Intermittent antiretroviral therapy in patients with controlled HIV infection","volume":"21","author":"Marchou","year":"2007","journal-title":"AIDS"},{"key":"R17-9-20210130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00002030-200402200-00010","article-title":"Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial","volume":"18","author":"Maggiolo","year":"2004","journal-title":"AIDS"},{"key":"R18-9-20210130","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/01.qai.0000230321.85911.db","article-title":"Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences","volume":"42","author":"Touloumi","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-9-20210130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.aids.0000161774.29029.0e","article-title":"Biphasic decline of CD4 cell count during scheduled treatment interruptions","volume":"19","author":"Fagard","year":"2005","journal-title":"AIDS"},{"key":"R20-9-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.aids.0000256414.91105.8e","article-title":"Intermittent therapy for the treatment of chronic HIV infection","volume":"21","author":"Ananworanich","year":"2007","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200801110-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:47:22Z","timestamp":1786038442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200801110-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,11]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282f2d760","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1103459.560359","asserted-by":"object"}]},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1,11]]}}}